BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 8893180)

  • 1. Evolution of anemia of chronic renal failure after the treatment of hyperparathyroidism.
    Garcia-Canton C; Palomar R; Moreno A; Toledo A; Suria S; Esparza N; Rossique P; Checa MD
    Nephron; 1996; 74(2):444-5. PubMed ID: 8893180
    [No Abstract]   [Full Text] [Related]  

  • 2. Parathyroidectomy and response to erythropoietin therapy in anaemic patients with chronic renal failure.
    Mandolfo S; Malberti F; Farina M; Villa G; Scanziani R; Surian M; Imbasciati E
    Nephrol Dial Transplant; 1998 Oct; 13(10):2708-9. PubMed ID: 9794600
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients.
    Lin CL; Hung CC; Yang CT; Huang CC
    Ren Fail; 2004 May; 26(3):289-95. PubMed ID: 15354979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for differences in dose requirements of recombinant human erythropoietin in haemodialysis patients.
    Scigalla P; Messinger D; Wieczorek L
    Contrib Nephrol; 1990; 82():55-64. PubMed ID: 2093527
    [No Abstract]   [Full Text] [Related]  

  • 5. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin treatment: influence of haemoglobin concentration on dialyser creatinine clearance in haemodialysed patients.
    Zehnder C
    Nephron; 1989; 51(3):424-5. PubMed ID: 2918959
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
    Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
    Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of polytransfused hemodialysis patients with recombinant human erythropoietin.
    Bommer J; Huber W; Tewes G; Ritz E; von Wedel S; Küppers S; Weinreich T; Bommer G
    Contrib Nephrol; 1988; 66():131-8. PubMed ID: 3391027
    [No Abstract]   [Full Text] [Related]  

  • 10. Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin.
    Jones-Lecointe A; Green PJ; Lee HA
    Clin Lab Haematol; 1991; 13(3):251-3. PubMed ID: 1794227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
    Marsden JT; Sherwood RA; Hillis A; Peters TJ
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of calcitriol on renal anemia in patients under chronic hemodialysis].
    Abou-Khalil N; Makó J
    Orv Hetil; 1996 Jul; 137(27):1469-72. PubMed ID: 9173368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin for anemia of renal failure in sickle cell disease.
    Steinberg MH
    N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy.
    Goicoechea M; Gomez-Campdera F; Polo JR; Tejedor A; Ruiz MA; Vazquez I; Verde E; Valderrabano F
    Clin Nephrol; 1996 Jun; 45(6):420-1. PubMed ID: 8793241
    [No Abstract]   [Full Text] [Related]  

  • 17. A Woman with ESRD with Increasing Need for Erythropoietin to Maintain Hemoglobin.
    Koncicki HM; Fishbane S
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1173-1175. PubMed ID: 28522653
    [No Abstract]   [Full Text] [Related]  

  • 18. Urea kinetics in patients on regular dialysis treatment before and after treatment with recombinant human erythropoietin.
    Zehnter E; Pollok M; Ziegenhagen D; Bramsiepe P; Longere F; Baldamus CA; Wellner U; Waters W
    Contrib Nephrol; 1988; 66():149-55. PubMed ID: 3391029
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of withdrawing erythropoietin.
    Taylor JE; Henderson IS; Mactier RA; Stewart WK
    BMJ; 1991 Feb; 302(6771):272-3. PubMed ID: 1998794
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant erythropoietin for the anemia of chronic renal failure.
    Ahmad R; Hand M
    N Engl J Med; 1987 Jul; 317(3):169-70. PubMed ID: 3600706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.